| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
2 companies
Hoffman Michael B serves as a Director at ANVS and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 12 buys and 6 sells. Those positions are worth an estimated $11.1M at current prices.
Historically, Hoffman Michael B's trades have earned a below-average insider score of 42/100 across 5 rated trades. On a 3-month view, 40.0% of the rated trades came out ahead, averaging -14.7% over three months.
The biggest single holding is ANVS (~$11.1M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 1,128,143 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | ANVS Annovis Bio, Inc. | Director | Buy | 45,000 | $4.31 | $193,794.00 | +1.8% | -40.2% | - | |
| Nov 24, 2025 | ANVS Annovis Bio, Inc. | Director | Buy | 39,200 | $4.08 | $159,886.07 | +1.6% | -41.6% | - | |
| Nov 21, 2025 | ANVS Annovis Bio, Inc. | Director | Buy | 20,000 | $3.50 | $69,900.00 | +0.8% | -36.4% | - | |
| Nov 14, 2025 | ANVS Annovis Bio, Inc. | Director | Buy | 15,000 | $2.11 | $31,650.00 | +0.6% | +3.8% | - | |
| Oct 28, 2025 | ANVS Annovis Bio, Inc. | Director | Buy | 975,610 | $2.05 | $2,000,000.50 | +65.9% | +41.0% | - | |
| Aug 27, 2020 | TRAW Traws Pharma, Inc. | Director | Sell | 184,368 | $0.27 | $50,129.66 | -100% | - | - | |
| Jan 31, 2020 | ANVS Annovis Bio, Inc. | Director, 10% Owner | Buy | 33,333 | $6.00 | $199,998.00 | +233.3% | - | - | |
| Aug 29, 2018 | TRAW Traws Pharma, Inc. | Director | Sell | 99,999 | $0.45 | $45,187.67 | -1.7% | - | - | |
| Apr 27, 2018 | TRAW Traws Pharma, Inc. | Director | Buy | 2,211,765 | $0.00 | - | +225.5% | - | - |